Extension of Time to File SOU

BREDAYGIO

Adagio Therapeutics, Inc.

Request for Extension of Time to File a Statement of Use

PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90671404
LAW OFFICE ASSIGNED LAW OFFICE 128
MARK SECTION
MARK BREDAYGIO (see, http://uspto.report/TM/90671404/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT BREDAYGIO
OWNER SECTION (current)
NAME Adagio Therapeutics, Inc.
MAILING ADDRESS 1601 Trapelo Road, Suite 178
CITY Waltham
STATE Massachusetts
ZIP/POSTAL CODE 02451
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
OWNER SECTION (proposed)
NAME Adagio Therapeutics, Inc.
MAILING ADDRESS 1601 Trapelo Road, Suite 178
CITY Waltham
STATE Massachusetts
ZIP/POSTAL CODE 02451
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME John Paul Oleksiuk
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@cooley.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) landrepont@cooley.com
CORRESPONDENCE INFORMATION (proposed)
NAME John Paul Oleksiuk
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@cooley.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) landrepont@cooley.com
DOCKET/REFERENCE NUMBER 342961-20000
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Pharmaceutical preparations and substances for the treatment and prevention of viruses; chemical, biochemical and microbial products, namely, antibodies being pharmaceutical preparations for the treatment and prevention of viruses
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 1
ALLOWANCE MAIL DATE 03/22/2022
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 1
SUBTOTAL AMOUNT [EXTENSION FEE] 125
TOTAL AMOUNT 125
SIGNATURE SECTION
SIGNATURE /Jill Andersen/
SIGNATORY'S NAME Jill Andersen
SIGNATORY'S POSITION Chief Legal Officer
DATE SIGNED 09/16/2022
SIGNATORY'S PHONE NUMBER N/A
SIGNATURE METHOD Sent to third party for signature
FILING INFORMATION
SUBMIT DATE Fri Sep 16 10:34:49 ET 2022
TEAS STAMP USPTO/ESU-XX.XX.XX.X-2022
0916103449742240-90671404
-800eb4a8c68394850aafb958
1e7dea53f8a05a5dd1553a42d
4faadd5196cab241-DA-34490
008-20220831160441609075



PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: BREDAYGIO (see, http://uspto.report/TM/90671404/mark.png)
SERIAL NUMBER: 90671404

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Adagio Therapeutics, Inc., having an address of
      1601 Trapelo Road, Suite 178
      Waltham, Massachusetts 02451
      United States
      Email: XXXX
Proposed: Adagio Therapeutics, Inc., having an address of
      1601 Trapelo Road, Suite 178
      Waltham, Massachusetts 02451
      United States
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 03/22/2022.

For International Class 005:
Current identification: Pharmaceutical preparations and substances for the treatment and prevention of viruses; chemical, biochemical and microbial products, namely, antibodies being pharmaceutical preparations for the treatment and prevention of viruses

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the first extension request.

Correspondence Information (current):
      John Paul Oleksiuk
      PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@cooley.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): landrepont@cooley.com

Correspondence Information (proposed):
      John Paul Oleksiuk
      PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@cooley.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): landrepont@cooley.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /Jill Andersen/      Date Signed: 09/16/2022
Signatory's Name: Jill Andersen
Signatory's Position: Chief Legal Officer
Signatory's Phone: N/A
Signature method: Sent to third party for signature

PAYMENT: 90671404
PAYMENT DATE: 09/16/2022

Serial Number: 90671404
Internet Transmission Date: Fri Sep 16 10:34:49 ET 2022
TEAS Stamp: USPTO/ESU-XX.XX.XX.X-2022091610344974224
0-90671404-800eb4a8c68394850aafb9581e7de
a53f8a05a5dd1553a42d4faadd5196cab241-DA-
34490008-20220831160441609075




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed